A recombinant signallingselective activated protein C that lacks anticoagulant activity is efficacious and safe in cutaneous wound preclinical models
Their metabolism and biology differ significantly from humans, and what works for a Wolverine enthusiast might be toxic for a Golden Retriever. The biggest concern is the lack of safety data, says Dr
While some patients report improved energy , clinical evidence is still developing
Active cancer or history of malignancy Pregnancy or breastfeeding Known peptide allergies Athletes subject to anti-doping testing (WADA prohibited) Raynauds disease or phenomenon Cold urticaria (hives from cold) Uncontrolled hypertension Peripheral vascular disease Open wounds (for local application) Pregnancy Cardiovascular conditions Diabetes (especially with neuropathy) Current infections Immunosuppression Blood clotting disorders Quality control issues represent perhaps the greatest practical risk with BPC-157
Mioduchoski, FNP-BC, with physician-supervised care protocols and a focus on safe, individualized treatment planning
May support broader healing of the digestive tract
